This article looks at some of the pros and cons of using Depo-Provera.
It also discusses some other things you might want to consider before you try this form of birth control.
Disadvantages of Depo Provera
It’s common for birth control to have disadvantages.
B. Boissonnet / Getty Images
Some disadvantages of Depo-Provera are described below.
This is because Depo-SubQ Provera 104 contains 31% less progestin.
This side effect is especially common during the first three months.
Weight Gain
Weight gainhas been associated with use of the Depo shot.
Mild Pain
Some women report mild pain associated with the Depo injection.
Appropriate Use
Depo-Provera can be a safe birth control option for most healthy women.
It’s important that you discuss your complete medical history with your healthcare provider before receiving an injection.
Depo-subQ Provera 104 is also approved for the treatment ofendometriosis pain.
Both Depo-Provera versions can also help lower your uterine cancer risk.
Medicaid maycover the costas well.
Any changes to the Affordable Care Act may affect whether insurance plans cover contraception.
Check with your insurance plan to see what your coverage and costs may be.
Summary
Like other forms of birth control, Depo-Provera has pros and cons.
Some people also experience very light or even absent periods while using Depo-Provera.
Some of Depo-Provera’s disadvantages include weight gain, irregular bleeding, and bone loss.
U.S. Food and Drug Administration: FDA AccessData.Physicial information: Depo-Provera contraceptive injection.
2013;78(1):116-24.
Food and Drug Administration.Depo-Provera physician information.
American Academy of Family Physicians.How to switch birth control methods.Am Fam Physician.
2011;83(5):575-576.
Quaas AM, Weedin EA, Hansen KR.On-label and off-label rug use in the treatment of endometriosis.Fertility and Sterility.
Bonnema R, McNamara M, Spencer A.Contraception choices in women with underlying medical conditions.Am Fam Physician.
2010;82(6):621-628.
Centers for Disease Control and Prevention.U.S.
selected practice recommendations for contraceptive use.
2015;103(3):612-25. doi:10.1016/j.fertnstert.2015.01.006
